The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 19

More JCP Articles

JCP
Schizophrenia: Salient Symptoms and Pathophysiology
Commentary

January 18, 2023

This article notes the distinction between positive and negative schizophrenic symptoms and provides an updated overview of disease pathophysiology.
Dawn I. Velligan, Sanjai Rao
JCP
Adverse Events and Treatment Adherence in Schizophrenia
Commentary

January 18, 2023

This article examines the effects of treatment-related adverse events on adherence to medication and strategies to improve adherence in practice.
Dawn I. Velligan, Sanjai Rao
JCP
The Epidemiology and Global Burden of Schizophrenia
Commentary

January 18, 2023

This article explores the costs and burden of schizophrenia and provides an overview of disease prevalence, incidence, and trends over time.
Dawn I. Velligan, Sanjai Rao
JCP
Optimizing Therapy Selection, Sequencing in Schizophrenia
Commentary

January 18, 2023

This article summarizes the current treatment landscape in schizophrenia, along with contexts in which agents should be prescribed.
Dawn I. Velligan, Sanjai Rao
JCP
Defining and Achieving Treatment Recovery in Schizophrenia
Commentary

January 18, 2023

This article defines treatment recovery in schizophrenia and summarizes strategies clinicians can pursue to improve patient outcomes.
Dawn I. Velligan, Sanjai Rao
JCP
Atomoxetine and Prevalence of Major Congenital Malformations
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
Gabriella Bröms, Sonia Hernández-Díaz, Krista F. Huybrechts, et al
JCP
Community Navigation Service for People With Serious Mental Illness
Original Research

January 16, 2023

Opening Doors to Recovery, a recovery support model, led to fewer days hospitalized, fewer arrests, and greater satisfaction with housing.
Michael T. Compton, Mary E. Kelley, Simone Anderson, et al
JCP
Actualizing and Sustaining Recovery-Oriented Care
Commentary

January 16, 2023

Jack Tsai, PhD, comments on intensity of therapy and scalability issues in a recent study of the Opening Doors to Recovery program for SMI.
Jack Tsai
JCP
Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video
Insight videos

January 14, 2023

Evaluating different domains of negative symptoms separately to better understand their impact on functional outcomes, particularly cognitive symptoms, is important in the treatment of patients with schizophrenia, especially intervening…
Dawn I. Velligan, Sanjai Rao
JCP
Treating Schizophrenia: Side Effects and Adherence Video
Insight videos

January 14, 2023

One of the central gaps that can affect treatment adherence for individuals with schizophrenia is side effects. Adverse events can lead to substantial impacts across all aspects of daily…
Sanjai Rao
JCP
Sequencing Therapy in the Treatment of Schizophrenia Video
Insight videos

January 14, 2023

Balancing and optimizing safety and efficacy when treating patients with schizophrenia can be challenging. New approaches to treatment may impact symptoms more effectively and contribute to better adherence. Sequencing,…
Sanjai Rao
JCP
Shared Decision Making in Schizophrenia Treatment Video
Insight videos

January 14, 2023

Although there are now multiple medications available to treat schizophrenia, many gaps still exist as a barrier to treatment success resulting in lower quality of life for this patient…
Dawn I. Velligan, Sanjai Rao

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe